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Abstract
The coronavirus disease-2019 (COVID-19) pandemic is a global health crisis that has 
generated fear and negative psychological consequences. The present study evaluated the 
validity and factor structure of Fear of COVID-19 Scale (FCV-19S) among a sample from 
the general Indonesian population. The English version of the FCV-19S was translated 
and back-translated into Indonesian language, followed by a pilot study. Using conveni-
ence sampling method, a total of 728 participants completed an online survey distributed 
on various social media platforms. The survey included the FCV-19S, personality traits 
(neuroticism and extraversion), Positive and Negative Affect Scale (PANAS), Generalized 
Anxiety Disorder Scale (GAD-7), and the nine-item Patient Health Questionnaire (PHQ-
9). The Indonesian FCV-19S had very good internal consistency (Cronbach’s alpha and 
McDonald’s omega) and composite reliability (alpha = 0.88, omega = .86, composite reli-
ability = .87). Maximum likelihood confirmatory factor analysis (CFA) was conducted 
to test construct validity (χ2/df = 2.51, CFI = .984, SRMR = .028, PCLOSE = .15 > .05, 
RMSEA = .06, 90% CI [.03, .09]). As for criterion-related validity, the FCV-19S score pos-
itively correlated with the score on PHQ-9, GAD-7, negative affect, and neuroticism and 
negatively correlated with extraversion. Negative affect was identified as the most impor-
tant predictor of the fear of COVID-19. Personality traits also predicted the fear of COVID-
19. The findings provide evidence that the FCV-19S is a reliable and valid instrument for 
assessing fear generated by COVID-19 among a healthy Indonesian-speaking population.
Keywords COVID-19 · Anxiety · Depression · Fear of COVID-19 · Negative affect; 
Personality · Extraversion · Neuroticism
The coronavirus disease-2019 (COVID-19) has resulted in both a physical and men-
tal health crisis (Wang et  al., 2020a). Learning from previous pandemics (e.g., SARS), 
COVID-19 is much more than just a medical challenge. The potential impact of the pan-
demic on the mental health of many nations is of increasing global concern (Mamun et al., 
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2020; Feng et al., 2020). Like any health disaster, the pandemic has generated fear, anxi-
ety, stress, and emotional exhaustion (Satici et al., 2020; Taylor et al., 2020; Arpaci et al., 
2020). These negative psychosocial consequences, coupled with uncertainty, can poten-
tially disrupt individual well-being and lead to maladaptive behaviors (Holmes et al., 2020; 
Li et al., 2020). While health systems around the world have concentrated on treating the 
physical effects of COVID-19, psychological well-being and emotional aspects also have to 
be considered (Wang et al., 2020a). Psychological and emotional factors play a substantial 
role in the success or failure of medical efforts and managing methods of pandemic control 
(e.g., vaccines and antiviral medication, hygiene practices, and spatial distancing). As a 
consequence of the pandemic, preliminary psychological research has identified fear as a 
unique and negative psychological and emotional factor, for all groups and across gender 
(Martínez-Lorca et al., 2020).
Fear is an automatic adaptive emotional response that occurs in stressful conditions in rela-
tion to a specific external danger (Steimer, 2002). In relation to the pandemic, fear can be 
a motivating factor that facilitates protective and preventive behavior among individuals to 
avoid infection and in following pandemic health instructions. However, intense and unregu-
lated fear may lead to a series of psychological (e.g., anxiety) and behavioral consequences 
(Holmes et al., 2020; Sep et al., 2019; Winter et al., 2020; Harper et al., 2020). For instance, 
excessive fear can undermine complex information processing and social interaction. Fear of 
infection or infecting family members is one of the most common reactions during pandemics 
(Ahorsu et al., 2020; Choi et al., 2020) that can result in health anxiety, worry, specific pho-
bias, and psychological distress (Arpaci et al., 2020; Qiu et al., 2020; Fernández et al., 2020; 
Nazari et al., 2021).
Recently, Ahorsu et  al. (2020) developed a brief, psychometrically robust instrument to 
assess the fear specifically generated by COVID-19 (the Fear of COVID-19 Scale; FCV-19S). 
The FCV-19S has already been validated in many different countries and across different 
cohorts with very good psychometric properties (e.g., Martínez-Lorca et al., 2020); Mertens 
et al., 2020; Soraci et al., 2020; Tzur Bitan et al., 2020). However, there is a lack of infor-
mation regarding the psychopathological mechanisms (e.g., positive and negative emotion) or 
personality traits associated with the fear of COVID-19.
Neuroticism and extraversion, in particular, are well recognized as significant predictors 
of change in positive and negative moods. High negative affect levels (e.g., feeling depressed 
and feeling ashamed) and mood fluctuations characterize neuroticism. While neuroticism pos-
itively predicts depression and anxiety, extraversion negatively affects them. These personality 
traits can be potentially relevant for understanding maladaptive behaviors during stressful situ-
ations (Strickhouser et al., 2017). For example, there is evidence that high neuroticism and low 
extraversion predict feelings of hopelessness (Chioqueta & Stiles, 2005), which is associated 
with suicidal behavior (Thakur & Jain, 2020). More specifically, neuroticism has been identi-
fied as a vulnerability factor for affective disorders (e.g., depression). Importantly, neuroticism 
accompanied by unstable negative affective states can elevate anxiety, which is a predictor for 
suicide (Serafini et al., 2020).
The Present Study
For the WHO, COVID-19 is much more than a medical challenge. There is also a men-
tal health crisis with possible long-lasting and profound adverse consequences. It is pos-
sible that the number of individuals affected by the fear of the pandemic quickly overtakes 
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those infected with it (Grover et al., 2020). Therefore, understanding the pandemic’s effects 
on psychological health is of great importance (Pfefferbaum & North, 2020; Wang et al., 
2020a, 2020b), particularly among vulnerable groups (e.g., adolescents and emerging 
adults including students) who are generally considered to be a population at risk from a 
mental health point of view (Brooks et al., 2020).
In early March 2020, the Indonesian government underestimated the dangers of 
COVID-19, and the virus continued to spread gradually to all Indonesian provinces within 
a month. At the time of writing (May 2021), Indonesia has the highest number of posi-
tive cases among Southeast Asian countries with over 1.42 million cases and one of the 
world’s highest death rates. The government’s decision, which emphasized economic con-
cerns rather than the health interest of the Indonesian people, contributed to the significant 
increase of positive cases in Indonesia. At present, Indonesia is in an arguable “do or die” 
situation because the increasing number of positive cases has almost collapsed the health 
system. Effective screening is the cornerstone for identifying and then treating pandemic-
related psychological and emotional adverse impacts. However, there is a lack of informa-
tion regarding the psychological impact of the COVID-19 pandemic in the general Indone-
sian population. Therefore, the present study attempted to validate the Indonesian version 
of FCV-19S and to evaluate its psychometric properties.
Method
Participants
A convenience sample of the general Indonesian population was recruited via social media 
platforms to participate in the present study. Data were collected from 728 participants 
(329 males; 399 females) aged 18 to 60 years (M = 26.56 years; SD = 0.87).
Measures
Fear of COVID-19 Scale (FCV-19S; Ahorsu et  al., 2020) The FCV-19S is a seven-item 
self-report unidimensional measure that assesses the fear of COVID-19. The scale com-
prises seven items reflecting emotional fear reactions towards the pandemic (e.g., “I am 
afraid of losing my life because of coronavirus-19”). Items are rated on a 5-point Likert-
type scale ranging from 1 (strongly disagree) to 5 (strongly agree). The total raw scores can 
range from 7 to 35. Higher scores indicate a greater fear of COVID-19. The psychometric 
properties of the FCV-19S are reported in “Results.” The Indonesian version of the scale 
can be found in the Appendix.
The Positive and Negative Affect Schedule (PANAS; Tellegen et al., 1988) The PANAS 
is a 20-item self-report scale that assesses positive affect (PA; ten items; e.g., strong) and 
negative affect (NA; ten items; e.g., scared) and describes different feelings and emotions 
over the past month. Each item is rated on a five-point scale from 1 (very slightly) to 5 
(extremely). The total raw score on each of the two subscales can range from 10 to 50. 
Higher scores indicate greater positive or negative experienced feelings in the past month. 
Internal reliability in the present study was very good (α = 0.80).
Brief Patient Health Questionnaire-9 (PHQ-9; Kroenke et  al., 2001) The nine-item 
PHQ-9 was used to assess both major depression and subthreshold depression in the past 
2 weeks. Each item (e.g., “Trouble falling or staying asleep, or sleeping too much”) is rated 
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on a 4-point scale ranging from 0 (not at all) to 3 (nearly every day). The PHQ-9 total 
score ranges from 0 to 27. Higher scores indicate more severe depression symptoms. For 
the present study, PHQ-9 total scores ≥ 15 were considered as moderately severe to severe 
depression. Internal reliability in the present study was very good (α = 0.85).
Generalized Anxiety Disorder (GAD; Spitzer et  al., 2006) The GAD-7 is a brief 
seven-item scale used to assess the severity of anxiety symptoms over the past 2 weeks. 
Each item (e.g., “Worrying too much about different things”) is scored on a 4-point scale 
ranging from 0 (not at all) to 3 (nearly every day). The total scores range from 0 to 21. 
Higher scores indicate more severe anxiety symptoms. For the present study, GAD-7 total 
scores ≥ 15 were considered as moderately severe to severe anxiety. Internal reliability in 
the present study was very good (α = 0.83).
Brief 10-Item Big Five Inventory (BFI-10; Rammstedt & John, 2007) The BFI-10 is a 
brief scale that assesses the “big five” personality traits, two items for each trait. In the pre-
sent study, only neuroticism and extraversion were assessed. Participants rated two items 
assessing neuroticism (e.g., “I see myself as someone who gets nervous easily”) and two 
items assessing extraversion (e.g., “I see myself as someone who has an active imagina-
tion”), on a scale ranging from 1 (strongly disagree) to 5 (strongly agree). A higher score 
on each subscale indicates a higher level of that specific individual personality trait. Inter-
nal reliability of two dimensions in the present study was very good (α = 0.81).
Procedure
Ethics  All study methods and procedures were reviewed and approved by the research 
team’s Institutional Human Research Ethics Committee. The committee approved the 
research protocol to ensure participant confidentiality, sampling, and informed consent. 
The original scale’s corresponding author granted permission to translate and validate the 
FCV-19S. All participants provided written informed consent.
Transcultural Adaptation of the FCV‑19S Scale Translation of the English version of the 
FCV-19S was carried out according to international guidelines (Beaton et al., 2000). In the 
first step, two Indonesian translators independently translated the FCV-19S from English to 
Indonesian. One of the translators was aware of the concepts being examined in the scale (a 
psychologist). The other translator was neither aware nor informed of the concepts and had 
no medical or clinical background. To synthesize a consensus version, an expert committee 
evaluated both versions. Then, an English translator completed a backward Indonesian-to-
English of the consensual version. There were no major changes made during this cultural 
adaptation.
Pilot Study In the pre-test, a pilot study was performed with 28 participants selected from 
the target population to test for the readability of the scale to be delivered in an online 
survey. The participant debriefing was conducted to identify actual and potential linguistic 
understanding, grammar, and ambiguity.
Participant Recruitment  The study was conducted during the COVID-19 pandemic (July 
to August 2020), so all data were collected online because face-to-face data collection was 
not possible. The participants were recruited over a 3-week period. The survey was con-
structed using Google Forms and only distributed online. The recruitment process included 
advertising the study in online social media (Instagram, Twitter, and Facebook) with links 
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to the survey available on the social media platforms. Also, the link was distributed and 
posted in online community platforms such as university forums and public forums. Once 
the link was clicked, it led to an informed consent page to be read and agreed upon by 
before proceeding to the survey. Only those who provided informed consent given were 
involved in this study. The informed consent page included information about the study 
such as the study’s objectives and duration, assurances of anonymity and confidentiality, 
and voluntary participation. It is also stated that the participants could only complete the 
survey once. The inclusion criteria were being aged over 18  years, being an Indonesian 
native, and currently living in Indonesia. A small economic reward was given for com-
pleting the survey. A small economic reward was given for completing the survey. The 
reward was in the form of electronic money in which participants could choose which type 
of electronic money they used already from the available services in Indonesia. The reward 
was then transferred to the participant’s electronic money account according to their stated 
preference.
Sample Size  A priori power analysis for multiple linear regression was calculated using 
G-Power, using an alpha of 0.05, a power of 0.80, Cohen’s f2 = 0.02, and four predictors to 
determine the sample size (Faul et al., 2009). The effect size value (Cohen’s f2 = 0.02) sig-
nifies small effect sizes, according to Cohen’s guidelines (Cohen, 1988). The desired total 
sample size was 602. In total, 728 participants were recruited in the present study which 
allowed for a 15% loss of data.
Data Analysis There were no missing values in the assessed variables; therefore, no impu-
tation method was implemented. Descriptive statistics were used to calculate the sample 
characteristics. Chi-squares, independent t-tests, and one-way ANOVAs were carried out to 
investigate the differences between groups. In the present study, simultaneous total scores 
of the PHQ ≥ 15 and the GAD-7 ≥ 15 were considered as comorbidity being experienced 
by the participants. Absolute skewness and kurtosis values assessed the normality assump-
tion. Variance inflation factor (VIF) was utilized to examine the multicollinearity issue 
(1 < VIF < 3) (Hair et al., 2018). Values of skewness and kurtosis were within <|1| which 
suggested the absence of severe violations of normality (Tabachnick & Fidell, 2014).
A maximum likelihood confirmatory factor analysis (CFA) was then conducted to 
evaluate unidimensional construct validity. The following values demonstrate an excellent 
fitting model (Hu & Bentler, 1999): 1 < χ2/df < 3, comparative fit index (CFI) > 0.95, root 
mean square error of approximation (RMSEA) < 0.06, and standardized root mean square 
residual (SRMR) < 0.06. To evaluate reliability, Cronbach coefficient, composite reliability 
(CR), and McDonald coefficient (ω) were used. Test–retest reliability was also conducted 
after 4 weeks. The Cronbach alpha if item deleted values and corrected item correlation 
values are shown in Table 2. ICC evaluated the test–retest reliability.
To evaluate convergent validity, the average variance extracted (AVE) was calculated 
(Henseler et al., 2016). To establish criterion-related validity, convergent validity, and dis-
criminant validity of the FCV-19S, correlation analyses were performed using the scores 
of the GAD-7, PHQ-9, and PANAS. Pearson correlations (r) of 0.10, 0.30, and 0.50 cor-
respond to small, medium, and large Cohen’s d effect sizes (Cohen, 1992).
A multiple linear stepwise regression analysis was carried out to test the impact of nega-
tive affect, personality traits, depression, and anxiety on fear of COVID-19 to investigate 
the best pattern of variables for predicting fear of COVID-19. The analysis proceeded on a 
stepwise basis by identifying the best predictors and eliminating the poor predictors. This 
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analysis is particularly appropriate where the objective is to predict with the highest pos-
sible accuracy rather than find explanatory models of influences on the dependent variable. 
All analyses were performed using SPSS version 25 (SPSS Inc., Chicago, IL) and AMOS 
version 24 with a two-sided 5% level of significance.
Results
Descriptive Statistics
The demographic characteristics of the sample are shown in Table  1. The univariate 
normality of the data was checked. Values of skewness and kurtosis for all 7 items of 
FCV-19S were within <|1|. The VIF for all 7 items of FCV-19S were in the acceptable 
range (1 < VIF < 3). Significant gender differences were found for anxiety (t [726] = 2.63, 
p = 0.01, Cohen’s d = 0.33, 95% [0.17, 0.49]), negative affect (t [726] = 2.75, p < 0.01, 
Cohen’s d = 0.37, 95% [0.21, 0.53]), and neuroticism (t [726] = 2.65, p < 0.01, Cohen’s 
d = 0.35, 95% [0.19, 0.51]). More specifically, females had significantly higher scores 
in negative affect (M = 31.32, SD = 7.51), anxiety (M = 9.15, SD = 4.88), and neuroti-
cism (M = 3.25, SD = 0.39) than males’ negative affect (M = 29.66, SD = 8.01), anxi-
ety (M = 8.12, SD = 8.01), and neuroticism (M = 3.18, SD = 0.28), respectively. No other 
gender differences were found on any other variables. A one-way between-participants 
ANOVA was carried out to compare the effect of age on GAD-7, PHQ-9, positive and 
negative affect, and neuroticism. Neuroticism was the only significant difference between 
age groups (F (2, 726) = 8.10, p < 0.01). Results also showed that 37% of participants 
obtained a GAD-7 score ≥ 15 (n = 269), and 23% of participants obtained a PHQ score ≥ 15 
(n = 167). A total of 18.8% participants simultaneously obtained a GAD-7 score ≥ 15 and a 
PHQ ≥ 15 (n = 137; see Table 1).
Psychometric Evolution
Maximum likelihood (ML) CFA on the FCV-19S was robust according to generated val-
ues (skewness < 2 and kurtosis < 7) in the normality test (Finney & DiStefano, 2013). The 
CFA produced an excellent fit for the model in the total sample (χ2/df = 2.51, CFI = 0.984, 
SRMR = 0.028, PCLOSE = 0.15 > 0.05, RMSEA = 0.06, 90% CI [0.03, 0.09]). The unidi-
mensional fear of COVID-19 construct was confirmed and is shown in Fig. 1.
The Cronbach alpha of the scale indicated good internal reliability (α = 0.88). The 
Cronbach alpha if item deleted values and the corrected item-total correlations were all 
well above the recommended level of 0.3 (see Table 2). The intraclass coefficient (ICC) 
was generated to evaluate the test–retest. After 4 weeks of the original validation study, 
the survey was sent to half of the participants (n = 350) who were randomly selected 
by a random number generator. Of these, 145 usable questionnaires were returned. In 
terms of consistency, the ICC was 0.68 with 95% CI [0.59, 0.71] for the single measure. 
The composite reliability and the McDonald coefficient values were both very good 
(CR = 0.87, omega = 0.86). The FCV-19S convergent validity was also acceptable 
(AVE = 0.51).
As for criterion-related validity, the FCV-19S score positively correlated with 
the score on PHQ-9 (r = 0.24, 95% CI [0.15, 0.22], p < 0.01), GAD-7 (r = 0.35, 95% 
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CI [0.25, 0.41], p < 0.01), neuroticism (r = 0.35, 95% CI [0.29, 0.41], p < 0.01), and 
negative affect (r = 0.56, 95% CI [0.69, 0.76], p < 0.01) and negatively correlated 
with extraversion (r =  − 0.16, 95% CI [− 0.25, − 0.11], p < 0.01) and positive affect 
(r =  − 0.05, p = 0.56). The full correlation matrix between all the variables is presented 
in Table 3.
The data were subjected to stepwise multiple regression analysis to ascertain the 
best predictors of Fear of COVID-19. A three-variable model was identified in which 
negative affect was found to have a b weight = 0.03, neuroticism a b weight of 0.37, 
and extraversion a b weight = 0.03. Negative affect was entered first and explained 
Table 1  Demographic characteristics of the sample (N = 728)
n, frequency; M, mean; SD, standard deviation; t, independent t-test to compare gender; FCV-19S, Fear 
of COVID-19 Scale, GAD-7, Generalized Anxiety Disorder scale; PHQ-9, Patient Health Questionnaire; 
PANAS-NA, Positive and Negative Affect Scale; NA, negative affect; PA, positive affect
Item Value Test p-value
Categorical variables
Gender, n (%)
  Males 243 (45.2) χ2 = 80.45  < .001
  Females 485 (54.8)
Age, n (%)
  18 to 24 years 227 (32.6) χ2 = 5.15 .07
  24 to 30 years 270 (37.0)
  Over 30 years 221 (30.4)
Education, n (%)
  Primary 240 (33) χ2 = 84.48  < .001
  Higher education 488 (67)
Depression, n (%)
  PHQ < 15 561 (77) χ2 = 16  < .001
  PHQ ≥ 15 167 (23)
Anxiety, n (%)
  GAD-7 < 15 459 (63) χ2 = 11  < .001
  GAD-7 ≥ 15 269 (37)
Comorbidity, n (%)
  PHQ ≥ 15 and GAD-7 ≥ 15 137 (18.8) χ2 = 28.97  < .001
    Male 37 (30.7)
    Female 100 (69.3)
Continuous variables M (SD)
  Age (years) 26.67 5.09 t(1, 726) = 1.29 .20
  PHQ-9 10.09 5.55 t(1, 726) = 1.52 .13
  GAD-7 8.81 4.95 t(1, 726) = 2.63 .01
  FCV-19S 3.11 .41 t(1, 726) = 1.80 .07
  Neuroticism 3.20 .32 t(1, 726) = 2.67 .01
  Extraversion 3.44 .71 t(1, 726) = .33 .73
  PANAS-NA 35.87 6.11 t(1, 726) = 2.75  < .01
  PANAS-PA 30.77 7.71 t(1, 726) = .78 .44
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28% of the variance in the fear of COVID-19 [F(1, 726) = 281.9, p < 0.001; with R2 
change = 0.28, standard error = 0.35]. Second, neuroticism was entered and explained 
a further 12% [F (1, 725) = 93.71, p < 0.001]. Finally, extraversion was entered 
and explained a further 1% [F (1, 724) = 9.21, p = 002]. In total, the three-variable 
model explained approximately 37% of the variance in fear of COVID-19 (adjusted 
R2 = 0.368). The stepwise regression model coefficients are shown in Table 4.
Fig. 1  The unidimensional Fear of COVID-19 Scale construct and factor loading
Table 2  Item descriptive statistics
M, mean; SD, standard deviation; a, absolute values;
VIF, variance inflation factor
Item number Item M SD Skewnessa Kurtosisa Corrected item-
total correlation
Cronbach’s alpha 
if item deleted
VIF
1 FCV1 2.31 .98 .20  − .90 .55 .870 1.61
2 FCV2 2.03 1.02 .60  − .67 .56 .870 1.64
3 FCV3 2.06 1.10 .62  − .71 .60 .867 1.89
4 FCV4 2.28 1.03 .34  − .76 .49 .873 1.53
5 FCV5 2.46 .98 .24  − .73 .62 .867 1.85
6 FCV6 2.54 1.05 .03  − 1.02 .53 .871 1.6
7 FCV7 2.44 1.03 .19  − 1.05 .46 .874 1.55
International Journal of Mental Health and Addiction 
1 3
Discussion
The optimal dimensions of psychosocial well-being for individuals during the pandemic 
need empirical investigation. The fear of COVID-19 is associated with an array of nega-
tive psychological symptoms, social interference, and physical disability that can com-
promise psychological well-being. Therefore, the present study was conducted to evalu-
ate the validity and factor structure of the Indonesian FCV-19S. The results demonstrated 
that FCV-19S is a valid and reliable instrument to assess fear of COVID-19 among the 
general Indonesian population and confirmed the unidimensional factor structure found in 
many previous studies in other communities such as Iranian (Ahorsu et al., 2020), Italian 
(Soraci et  al., 2020), Bangla (Sakib et  al., 2020), Arabic (Alyami et  al., 2020), English 
(Winter et al., 2020), Turkish (Haktanir et al., 2020; Satici et al., 2020), French (Mailliez 
et al., 2021), Taiwan (Chang et al., 2020), Malay (Pang et al., 2020), North American (Perz 
et al., 2020), Cuban (Broche-Pérez et al., 2020), Pakistani (Mahmood et al., 2020), Mexico 
Table 3  Correlation matrix of main variables
FCV-19S, Fear of COVID-19 Scale; GAD-7, Generalized Anxiety Disorder scale; PHQ-9, Patient Health 
Questionnaire; PANAS-NA, Positive and Negative Affect Scale (negative affect); PANAS-PA, Positive and 
Negative Affect Scale (positive affect)
** Correlation significant at the p < .01 level (two-tailed)
* Correlation significant at the p < .05 level (two-tailed)
Measure FCV-19S Gender GAD-7 PHQ-9 PANAS-NA Neuroticism Extraversion
FCV-19S 1.00
Gender .07
GAD-7 .37** .09**
PHQ-9 .24** .06 .72**
PANAS-NA .53** .10** .64** .52**
Neuroticism .35** .15** .11** .06 .13**
Extraversion  − .16  − .05  − .13  − .15  − .14*  − .09*
PANAS-PA  − .05  − .03  − .29**  − .37**  − .21**  − .08* .22**
Table 4  Multiple linear stepwise regression analysis (N = 728)
a Dependent variable: fear of COVID-19
b Unstandardized coefficients, SE, standard error; β, standardized coefficients
CI, confidence interval;
VIF, variance inflation factor
Model Predictor variable b SE Beta t p R R2 ANOVA
F df
1 Negative affect .03 .01 .53 16.79  < .001 .53a .279 281.9 (1,726)
2 Negative affect .03 .01 .49 16.45  < .001 .60a .360 205.8 (2,725)
Neuroticism .37 .04 .29 9.68  < .001
3 Negative affect .03 .01 .48 16.08  < .001 .61a .368 141.8 (3,724)
Neuroticism .37 .04 .29 9.78  < .001
Extraversion -.05 .02 -.1 -3.03 .002
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(García-Reyna et  al., 2020), Japanese (Masuyama et  al., 2020), and Greek (Nikopoulou 
et al., 2020; Tsipropoulou et al., 2020). The evaluation of reliability and internal consist-
ency, tested by Cronbach alpha, composite reliability, and McDonald’s construct reliabil-
ity, all demonstrated that the Indonesian FCV-19S had very good reliability. The Cronbach 
for the present study (α = 0.88) higher than original Persian study (α = 0.82, N = 771), the 
Bangla version (α = 0.87. N = 8550), the Greek version (α = 0.87. N = 2970), French ver-
sion (α = 0.87, N = 371), Turkish (α = 0.86, N = 668), Italian (α = 0.871, N = 251), and simi-
lar to the Arabic (α = 0.88. N = 693), and lower than English version (α = 0.89, N = 1397) 
(Winter et al, 2020).
To evaluate criterion-related validity, convergent validity, and discriminant validity, the 
FCV-19S was correlated against measures for depression (PHQ-9), anxiety (GAD-7), neg-
ative affect (PANAS-NA), positive affect (PANAS-PA), neuroticism, and extraversion and 
(as expected) positive associations were found with all of them except positive affect and 
extraversion. Overall, these findings indicate acceptable criterion-related validity, conver-
gent validity, and discriminant validity.
Significant gender differences were found in total negative affect, anxiety, and neuroti-
cism. These findings concur with previous studies indicating that females report greater 
psychological problems and are more likely to develop anxiety symptoms and be neurotic 
compared to males (Blüml et al., 2013). In line with recent studies, females reported more 
psychological problems associated with COVID-19 than males (e.g., Badahdah et  al., 
2020; Qiu et al., 2020; Fernández et al., 2020).
Based on the findings, the estimated prevalence of moderately severe to severe depres-
sion was 23%, and the estimated prevalence of moderately severe to severe anxiety was 
37%. The study’s prevalence was slightly higher than the rates during the COVID-19 
pandemic reported among populations in China (Wang et al., 2020a, 2020b; 29% anxiety 
and 16% depression), Hong Kong (Choi et  al., 2020; 14% anxiety and 19% depression), 
Bangladesh (Islam et al., 2020; 15% anxiety and 18% depression), and Jordan (Naser et al., 
2020; 24% anxiety and 13% depression). In addition to the high prevalence of specific 
mental health disorders, 18.8% of the participants reported moderately severe comorbidity 
(i.e., they experienced both anxiety and depression).
Practical Implications
The patterns in relation to psychological reactions to pandemics are complex, and evi-
dence-based treatments must address such complexity. In the present study, greater fear 
of COVID-19 was associated with a greater negative affect and neuroticism. Neuroticism 
is a key trait associated with most emotional disorders (Brown & Barlow, 2009; Norton & 
Paulus, 2017). Other associated factors include anxiety sensitivity, worry, and emotional 
dysregulation (MacNamara et  al., 2015), and have frequently been reported during the 
COVID-19 pandemic (e.g., Mertens et al., 2020; Restubog et al., 2020; Wu et al., 2021). 
These factors can be important in increasing or maintaining persistent negative emotions 
and may affect physical and psychological functioning (Sauer-Zavala et al., 2020). Neuroti-
cism has contributed to the psychopathology of adults during the COVID-19 pandemic and 
has been a predictor of both depression and generalized anxiety (Nikčević et  al., 2021). 
Individuals high in the trait are sensitive to stress and threats of infection. Consequently, 
neuroticism may be associated with vulnerability to elevated psychological distress dur-
ing pandemics. For example, individuals with higher levels of neuroticism and negative 
affect may be more likely to misinterpret the slightest of non-normal bodily sensations 
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as indications of serious disease (Ferguson, 2009). Therefore, it is not surprising that the 
severity of neuroticism and negative affects predict their fear of COVID-19.
Anxious or depressive mood states (Barlow et al., 2014) and fears of death and dying 
in both self and others (Loo, 1984; Zeigler-Hill, & Shackelford, 2020) have been found to 
be associated with higher neuroticism levels and negative affect in previous studies. The 
lifetime comorbidity of anxiety disorders with the major depressive disorder may be as 
high as 73% (Kessler et  al., 2005). Given the high prevalence of anxiety and depressive 
disorders and comorbidities during the current pandemic, disorder-specific interventions 
may be difficult to justify when the clinical reality is complex, and comorbidities are the 
norm (Holmes et  al., 2018). Transdiagnostic intervention can be potentially served as a 
promising intervention for individuals psychologically affected by the pandemic. Extraver-
sion traits may facilitate recovery from adverse effects of stressful situations (Nazari & 
Griffiths, 2020). Individuals with high extraversion traits appear to have a greater tendency 
to undertake healthy behaviors (Fredrickson & Joiner, 2018) and may have a higher adher-
ence to follow health instructions.
Limitations
The findings of the study must be interpreted in light of several limitations. The data col-
lected were during the initial COVID-19 outbreak; to minimize infection risk, the data col-
lection occurred online. Using an online data collection method may limit specific relevant 
population groups (e.g., disadvantaged groups) and other vulnerable groups. Therefore, the 
data cannot represent the views of these disadvantaged groups and affects the study find-
ings’ generalizability. However, online data collection tends to provide more honest and 
truthful responses than those utilizing offline methods (Griffiths, 2010). Another limitation 
of the present study was that the data relied entirely on self-report measures which have 
well-established methodological biases.
Conclusion
The findings of the present study provide evidence that FCV-19S is a reliable and valid 
instrument to assess fear of COVID-19. The Indonesian FCV-19 can be used in the preven-
tion and clinical research in Indonesia. The fear generated by the COVID-19 is also associ-
ated with depression, anxiety, negative affect, and neuroticism. The FCV-19S can empiri-
cally contribute to deeper understanding psychological consequences of the pandemic. The 
present findings highlight the importance of personality traits and in fear generated by the 
pandemic. The FCV-19S can be utilized by mental health staff to identify the risk groups 
based on sociodemographic characteristics. The present findings highlight the importance 
of personality traits in fear generated by the pandemic. In line with these findings, psychol-
ogists could develop targeted intervention programs to reduce fear generated by the pan-
demic. Empirically, studies conducted throughout the COVID-19 pandemic would benefit 
from including an assessment of COVID-19-related fear as outcome variables.
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Appendix. The Indonesian version of the Fear of COVID‑19
Instruksi: Dibawah ini terdapat beberapa pertanyaan mengenai perasaan, pikiran, ataupun 
perilaku Anda terkait dengan pandemik COVID-19. Bacalah setiap pertanyaan tersebut 
dengan baik dan berikan tanda centang (√) pada satu dari lima pilihan respons yang paling 
menggambarkan diri Anda saat ini.
Pernyataan Sangat 
Tidak 
Sesuai
Tidak Sesuai Netral Sesuai Sangat Sesuai
1. Saya takut pada COVID-19 □ □ □ □ □
2. Saya merasa tidak nyaman jika memikirkan 
tentang COVID-19
□ □ □ □ □
3. Tangan terasa lembab ketika saya memikir-
kan tentang COVID-19
□ □ □ □ □
4. Saya takut akan kehilangan nyawa karena 
COVID-19
□ □ □ □ □
5. Saat menonton berita atau mendengar cerita 
tentang COVID-19 di media sosial, saya 
menjadi gelisah dan cemas
□ □ □ □ □
6. Saya sulit tidur karena khawatir akan terpa-
par COVID-19
□ □ □ □ □
7. Jantung saya berdebar saat membayangkan 
terpapar COVID-19
□ □ □ □ □
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